Crassocephalum rabens, a novel phytogenic supplement, promotes weaned pig growth and gut health

Abstract Concerns over antimicrobial resistance have accelerated global bans on in-feed antibiotics, driving the search for sustainable alternatives in swine farming. This study evaluated the potential of the edible medicinal plant Crassocephalum rabens as a phytogenic feed additive and alternative to antibiotic growth promoters in weaned pigs. Ninety-six healthy weaning piglets were randomly assigned to three dietary treatments (n = 32 per group): a control basal diet (CTL), or a basal diet supplemented with 0.15% (low-dose, LCR) or 0.45% (high-dose, HCR) C. rabens plant powder, for seven weeks. Supplementation groups showed markedly improved feed conversion ratio, decreasing from 3.04 in the CTL to 1.93 in LCR and 1.87 in HCR. Diarrhea incidence dropped from 28.1% (CTL) to 9.4% (HCR) without in-feed antibiotics. Furthermore, C. rabens attenuated intestinal immunoglobulin A and serum tumor necrosis factor-alpha levels, indicating improved mucosal defense and anti-inflammatory activity. 16 S rRNA gene sequencing revealed that C. rabens modulated the gut microbiota by enriching beneficial bacteria and suppressing pathogens, as further confirmed in vitro by stimulating Lactobacillus reuteri and inhibiting Clostridium perfringens, Escherichia coli, and Salmonella enterica serovar Choleraesuis growth. Concurrently, a gas chromatography/mass spectrometry-based metabolomics study demonstrated significant shifts in glycerolipid and galactose metabolism in pig serum, which strongly correlated with the altered fecal microbiota in Spearman’s rank correlation analysis. Overall, C. rabens supplement effectively promoted growth and alleviated diarrhea via modulating gut microbiota and primary metabolism in weaned pigs, highlighting its potential to support antibiotic-free swine production. Key points • C. rabens significantly improves feed conversion ratio (FCR) and weight gain in weaned pigs. • Promoting gut health and beneficial microbes indicates improved disease resistance in weaning pigs. • C. rabens is a novel phytogenic supplement in piglet farming. Graphical abstract

Authors

Institutions

Publication Details

Journal
Applied Microbiology and Biotechnology
Published
2026-11-17
DOI
https://doi.org/10.1007/s00253-026-14098-0
Primary Topic
Animal Nutrition and Physiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Crassocephalum rabens, a novel phytogenic supplement, promotes weaned pig growth and gut health

Jeng‐Yuan Shiau, Lie‐Fen Shyur, Wen-Yuh Lin, Meng‐Ting Chang et al.
3 links
Applied Microbiology and Biotechnology
Animal Nutrition and Physiology
article

Crassocephalum rabens, a novel phytogenic supplement, promotes weaned pig growth and gut health

Jeng‐Yuan Shiau, Lie‐Fen Shyur, Wen-Yuh Lin, Meng‐Ting Chang, Yu-Hsin Chen, Chuan-Ju Lin, Yu-Chuan Liang, Yu-Hong Alexander Wang, Yuan-Wen Wen, Yu-Chia Chang, Chih-Ting Chang
article en

Abstract

Abstract Concerns over antimicrobial resistance have accelerated global bans on in-feed antibiotics, driving the search for sustainable alternatives in swine farming. This study evaluated the potential of the edible medicinal plant Crassocephalum rabens as a phytogenic feed additive and alternative to antibiotic growth promoters in weaned pigs. Ninety-six healthy weaning piglets were randomly assigned to three dietary treatments (n = 32 per group): a control basal diet (CTL), or a basal diet supplemented with 0.15% (low-dose, LCR) or 0.45% (high-dose, HCR) C. rabens plant powder, for seven weeks. Supplementation groups showed markedly improved feed conversion ratio, decreasing from 3.04 in the CTL to 1.93 in LCR and 1.87 in HCR. Diarrhea incidence dropped from 28.1% (CTL) to 9.4% (HCR) without in-feed antibiotics. Furthermore, C. rabens attenuated intestinal immunoglobulin A and serum tumor necrosis factor-alpha levels, indicating improved mucosal defense and anti-inflammatory activity. 16 S rRNA gene sequencing revealed that C. rabens modulated the gut microbiota by enriching beneficial bacteria and suppressing pathogens, as further confirmed in vitro by stimulating Lactobacillus reuteri and inhibiting Clostridium perfringens, Escherichia coli, and Salmonella enterica serovar Choleraesuis growth. Concurrently, a gas chromatography/mass spectrometry-based metabolomics study demonstrated significant shifts in glycerolipid and galactose metabolism in pig serum, which strongly correlated with the altered fecal microbiota in Spearman’s rank correlation analysis. Overall, C. rabens supplement effectively promoted growth and alleviated diarrhea via modulating gut microbiota and primary metabolism in weaned pigs, highlighting its potential to support antibiotic-free swine production. Key points • C. rabens significantly improves feed conversion ratio (FCR) and weight gain in weaned pigs. • Promoting gut health and beneficial microbes indicates improved disease resistance in weaning pigs. • C. rabens is a novel phytogenic supplement in piglet farming. Graphical abstract

Applied Microbiology and Biotechnology
Taiwan Livestock Research Institute (TW), Kaohsiung Medical University (TW), Tunghai University (TW), Council of Agriculture (TW), Taiwan Agricultural Research Institute Council of Agriculture, Executive Yuan (TW), Agricultural Biotechnology Research Center, Academia Sinica (TW), Taiwan Sugar Corporation (TW), Taipei Medical University (TW), Academia Sinica (TW)
Zero hunger, Good health and well-being
Animal Nutrition and Physiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon